Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26774| Title: | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma. | Austin Authors: | Arulananda, Surein;O'Brien, Megan;Evangelista, Marco;Harris, Tiffany J ;Steinohrt, Nikita S;Jenkins, Laura J;Walkiewicz, Marzena;O'Donoghue, Robert J J;Poh, Ashleigh R;Thapa, Bibhusal ;Williams, David S ;Leong, Trishe;Mariadason, John M ;Li, Xia;Cebon, Jonathan S ;Lee, Erinna F;John, Thomas ;Fairlie, Walter Douglas | Affiliation: | Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, Australia Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Mathematics and Statistics, La Trobe University, Bundoora, VIC, Australia Medical Oncology Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia Pathology Olivia Newton-John Cancer Research Institute School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia |
Issue Date: | 15-Jun-2021 | Date: | 2021 | Publication information: | Cell Death Discovery 2021; 7(1): 146 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26774 | DOI: | 10.1038/s41420-020-00388-7 | Journal: | Cell Death Discovery | PubMed URL: | 34131107 | ISSN: | 2058-7716 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.